Skip to content
S5S5S5100010001000

Drawing based on the label description. No photo yet.

“1,000 mg, brownish yellow, oval, biconvex, film-coated tablet, Boehringer Ingelheim company symbol and "S5" debossed on one side; the other side is debossed with "1000"”

S5 1000 pill

Pill with imprint S5 1000 is brown, oval, 21 mm and has been identified as Empagliflozin and Metformin Hydrochloride 5 mg / 1000 mg. It is used for type 2 diabetes. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.

Empagliflozin and Metformin Hydrochloride 5 mg / 1000 mg

Imprint
S5 1000
Strength
Empagliflozin 5 mg / Metformin Hydrochloride 1000 mg
Used for
Type 2 diabetes
Color
Brown
Shape
Oval
Size
21 mm
Score
No score line
Form
Tablet
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc
Drug class
Diabetes medicine (SGLT2 inhibitor)
NDC
0597-0175, 0597-0175-60, 0597-0175-18, 0597-0175-66

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Empagliflozin and Metformin pills and guides

What is Empagliflozin and Metformin used for?

Empagliflozin and Metformin is used for type 2 diabetes.

Medicine type
Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label

SYNJARDY

SYNJARDY is a combination of empagliflozin and metformin hydrochloride (HCl) immediate-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

SYNJARDY XR

SYNJARDY XR is a combination of empagliflozin and metformin HCl extended-release indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Empagliflozin

Empagliflozin, when used as a component of SYNJARDY or SYNJARDY XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:

  • Cardiovascular (CV) death in adults with established CV disease.
  • CV death and hospitalization for heart failure in adults with heart failure.
  • Sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with chronic kidney disease at risk of progression.

Limitations of Use

  • SYNJARDY and SYNJARDY XR are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients.
  • Because of the metformin HCl component, the use of SYNJARDY or SYNJARDY XR is limited to patients with type 2 diabetes mellitus for all indications.
  • Empagliflozin, when used as a component of SYNJARDY or SYNJARDY XR, is not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of intravenous immunosuppressive therapy or greater than 45 mg of prednisone or equivalent for kidney disease. Empagliflozin is not expected to be effective in these populations.

From the FDA-approved label on DailyMed (published Aug 27, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows S5 and the other side shows 1000.
  • It is brown, oval, 21 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Synjardy.

Ingredients

Active: Empagliflozin, Metformin Hydrochloride

Other pills with imprint S5 1000

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Empagliflozin and Metformin pills